294 related articles for article (PubMed ID: 9373919)
1. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
Bek-Jensen H; Tiselius HG
Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
[TBL] [Abstract][Full Text] [Related]
2. Evidence for disordered acid-base handling in calcium stone-forming patients.
Worcester EM; Bergsland KJ; Gillen DL; Coe FL
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
[TBL] [Abstract][Full Text] [Related]
3. Studies on crystalluria in calcium oxalate stone formers.
Ahlstrand C; Tiselius HG; Larsson L
Urol Res; 1984; 12(2):103-6. PubMed ID: 6539984
[TBL] [Abstract][Full Text] [Related]
4. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
Tiselius HG
Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
[TBL] [Abstract][Full Text] [Related]
5. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
6. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
Tiselius HG
Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
[TBL] [Abstract][Full Text] [Related]
7. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
Robertson WG
Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
[TBL] [Abstract][Full Text] [Related]
8. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
9. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.
Tiselius HG; Hallin A; Lindbäck B
Urol Res; 2001 Apr; 29(2):75-82. PubMed ID: 11396732
[TBL] [Abstract][Full Text] [Related]
10. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
11. Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children.
Rodriguez A; Saez-Torres C; Mir C; Casasayas P; Rodriguez N; Rodrigo D; Frontera G; Buades JM; Gomez C; Costa-Bauza A; Grases F
BMC Urol; 2018 Dec; 18(1):116. PubMed ID: 30567525
[TBL] [Abstract][Full Text] [Related]
12. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
Sikora P; Zajaczkowska M; Hoppe B
Pediatr Nephrol; 2009 Oct; 24(10):1997-2003. PubMed ID: 19333626
[TBL] [Abstract][Full Text] [Related]
13. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
Atmani F; Glenton PA; Khan SR
Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
[TBL] [Abstract][Full Text] [Related]
14. Standardized estimate of the ion activity product of calcium oxalate in urine from renal stone formers.
Tiselius HG
Eur Urol; 1989; 16(1):48-50. PubMed ID: 2714318
[TBL] [Abstract][Full Text] [Related]
15. The effect of pH on the risk of calcium oxalate crystallization in urine.
Berg C; Tiselius HG
Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
[TBL] [Abstract][Full Text] [Related]
16. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients.
Atmani F; Khan SR
Urol Int; 2002; 68(1):54-9. PubMed ID: 11803269
[TBL] [Abstract][Full Text] [Related]
17. Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.
Tiselius HG; Lindbäck B; Fornander AM; Nilsson MA
Urol Res; 2009 Aug; 37(4):181-92. PubMed ID: 19444436
[TBL] [Abstract][Full Text] [Related]
18. Repeated urine analysis in patients with calcium stone disease.
Bek-Jensen H; Tiselius HG
Eur Urol; 1998; 33(3):323-32. PubMed ID: 9555561
[TBL] [Abstract][Full Text] [Related]
19. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
20. Urine composition and stone formation during treatment with acetazolamide.
Ahlstrand C; Tiselius HG
Scand J Urol Nephrol; 1987; 21(3):225-8. PubMed ID: 3433023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
